Literature DB >> 16450772

Extended parotidectomy.

M De Vincentiis1, G Magliulo, P Soldo, V Manciocco, G Pagliuca, R Del Gaizo, A Gallo.   

Abstract

Malignant tumours of the parotid gland represent a group of relatively rare lesions. The medical records of 363 patients with parotid swelling treated between 1974 and 2003 at the "G. Ferreri" Department of Otorhinolaryngology, "La Sapienza" University in Rome were retrospectively analysed. Clinical presentation, pre-operative investigations, surgical procedure, histopathology report, post-operative complications, and the oncological results of 19 patients who underwent extended radical parotidectomy for malignant neoplasm of the parotid gland are discussed. Extended radical parotidectomy, reserved for neoplasms in an advanced stage, involves the removal of the entire parotid gland, with sacrifice of the facial nerve and the resection en bloc of the adjacent structures affected by neoplastic infiltration, such as the temporal bone, the mandibular bone, the skin, blood vessels and nerves. In addition to this surgical treatment, a cycle of adjuvant radiotherapy is also necessary. The overall rate of survival at 10 years depends mainly on the histological characteristics of the tumour, and, in this series, is reported to be approximately 58%. These data indicate that total extended radical parotidectomy combined with post-operative radiotherapy, represents the best therapeutic approach with regard both to quality of life and life expectancy, in patients with an advanced stage of malignant neoplasm of the parotid gland.

Entities:  

Mesh:

Year:  2005        PMID: 16450772      PMCID: PMC2639865     

Source DB:  PubMed          Journal:  Acta Otorhinolaryngol Ital        ISSN: 0392-100X            Impact factor:   2.124


  7 in total

1.  Salivary neoplasms: overview of a 35-year experience with 2,807 patients.

Authors:  R H Spiro
Journal:  Head Neck Surg       Date:  1986 Jan-Feb

2.  Salivary gland tumors: a 10-year retrospective study of survival in relation to size, histopathological examination of the tumor, and nodal status.

Authors:  N Dorairajan; S Periyasamy; Preetha Muthayya; R Manikandan; T Srinivasan; D Siddharth
Journal:  Int Surg       Date:  2004 Jul-Sep

3.  Prognostic factors for adenoid cystic carcinoma of the head and neck: a retrospective evaluation of 96 cases.

Authors:  K Hamper; F Lazar; M Dietel; J Caselitz; J Berger; H Arps; U Falkmer; G Auer; G Seifert
Journal:  J Oral Pathol Med       Date:  1990-03       Impact factor: 4.253

Review 4.  Current management of salivary gland tumors. Part 2.

Authors:  M E Johns; M M Goldsmith
Journal:  Oncology (Williston Park)       Date:  1989-03       Impact factor: 2.990

5.  The surgical management of advanced malignancies of the parotid gland.

Authors:  G P Katsantonis; W H Friedman; B N Rosenblum
Journal:  Otolaryngol Head Neck Surg       Date:  1989-12       Impact factor: 3.497

6.  Radical surgery following radiotherapy for advanced parotid carcinoma.

Authors:  M O Corcoran; H P Cook; M Hobsley
Journal:  Br J Surg       Date:  1983-05       Impact factor: 6.939

Review 7.  Salivary gland tumours.

Authors:  P M Speight; A W Barrett
Journal:  Oral Dis       Date:  2002-09       Impact factor: 3.511

  7 in total
  4 in total

1.  Outcomes of temporal bone resection for locally advanced parotid cancer.

Authors:  Saral Mehra; Luc G Morris; Jatin Shah; Mark Bilsky; Samuel Selesnick; Dennis H Kraus
Journal:  Skull Base       Date:  2011-11

2.  Non-enhanced MRI in combination with color Doppler flow imaging for improving diagnostic accuracy of parotid gland lesions.

Authors:  Wei Zhang; Zhichao Zuo; Ningbin Luo; Lianfeng Liu; Guanqiao Jin; Junjie Liu; Danke Su
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-02-12       Impact factor: 2.503

3.  Parotid surgery in patients over seventy-five years old.

Authors:  A Croce; L D'Agostino; A Moretti; A Augurio
Journal:  Acta Otorhinolaryngol Ital       Date:  2008-10       Impact factor: 2.124

4.  Sequelae following radical parotidectomy: the role of the reconstructive surgeon.

Authors:  James Allan; Jeon Cha; Johnny Kwei; John G Vandervord
Journal:  Eplasty       Date:  2014-03-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.